Caribou Biosciences Inc (CRBU)
1.79
-0.14
(-7.25%)
USD |
NASDAQ |
Jun 14, 16:00
1.82
+0.03
(+1.68%)
After-Hours: 20:00
Caribou Biosciences Total Assets (Quarterly): 406.82M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 406.82M |
| December 31, 2023 | 432.21M |
| September 30, 2023 | 457.52M |
| June 30, 2023 | 349.65M |
| March 31, 2023 | 347.46M |
| December 31, 2022 | 373.76M |
| September 30, 2022 | 398.82M |
| Date | Value |
|---|---|
| June 30, 2022 | 421.37M |
| March 31, 2022 | 446.00M |
| December 31, 2021 | 442.36M |
| September 30, 2021 | 461.96M |
| June 30, 2021 | 158.40M |
| March 31, 2021 | 167.96M |
| December 31, 2020 | 36.05M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
36.05M
Minimum
Dec 2020
461.96M
Maximum
Sep 2021
350.02M
Average
402.82M
Median
Total Assets (Quarterly) Benchmarks
| Guardant Health Inc | 1.705B |
| Regeneron Pharmaceuticals Inc | 34.37B |
| Sangamo Therapeutics Inc | 128.96M |
| Vertex Pharmaceuticals Inc | 23.92B |
| Bio-Path Holdings Inc | 1.768M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 63.54M |
| Shareholders Equity (Quarterly) | 343.29M |
| Current Ratio | 10.49 |